Company profile
Ocean Biomedical, Inc. CIK 1869974
Ticker
OCEA (OTC)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10022
Fiscal year end
2024 (FY)
Key Financials
Revenue
—
Net income
-$9.48M
Total assets
$902.0K
Total liabilities
$98.52M
Stockholders' equity
-$97.62M
Cash & equivalents
$200.0K
Operating income
-$3.80M
Operating cash flow
-$4.18M
Capital expenditures
—
Fiscal year 2024, via 10-K filed 2025-04-08. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
10,922.2%
Equity / assets
-10,822.2%
CapEx / revenue
—
Operating cash flow / net income
0.44×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
—
-$9.48M
$902.0K
$98.52M
-$97.62M
2023
—
-$114.47M
$5.50M
$96.26M
-$90.76M
2022
—
-$17.36M
$1.84M
$12.66M
-$10.82M
2021
—
—
$108.65M
$3.40M
-$6.66M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form NT 10-Q
2025-08-14
Financials filed via
Form 10-K
filed 2025-04-08
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
New York, NY 10022
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:46 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.